Abstract
To fully realize the potential of AI and digital, biopharma sponsors need a structured approach to upgrading tech infrastructure for efficient data capture and trial management.
Key Data
-
Publication Date13 February 2025
-
Primary AuthorJeffrey Lewis
-
SourceMcKinsey & Company
-
LanguageEnglish
Click below to visit original source: